# Impact of the sFlt-1/PlGF Ratio on Medical Decision-making and on Maternal and Neonatal Outcomes in Women Suspected of Preeclampsia

> **NCT06314555** · — · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Saint Etienne** · enrollment: 314 (actual)

## Conditions studied

- Preeclampsia Possible

## Interventions

- **OTHER:** Blood sample
- **OTHER:** Vascular-renal sample

## Key facts

- **NCT ID:** NCT06314555
- **Lead sponsor:** Centre Hospitalier Universitaire de Saint Etienne
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-01
- **Primary completion:** 2021-01-27
- **Final completion:** 2021-01-27
- **Target enrollment:** 314 (ACTUAL)
- **Last updated:** 2024-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06314555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06314555, "Impact of the sFlt-1/PlGF Ratio on Medical Decision-making and on Maternal and Neonatal Outcomes in Women Suspected of Preeclampsia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06314555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
